About Queen Elizabeth Hospital; Clinical Oncology
Clinical Trials at Queen Elizabeth Hospital; Clinical Oncology
During the past decade, Queen Elizabeth Hospital; Clinical Oncology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 7 clinical trials were completed, i.e. on
average, 116.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Queen Elizabeth Hospital; Clinical Oncology"
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Institut Jules Bordet/Clinical Trials Support Unit (IJB/CTSU)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Queen Elizabeth Hospital; Clinical Oncology
According to Clinical.Site data, the most researched conditions in "Queen Elizabeth Hospital; Clinical Oncology" are
"Breast Neoplasms" (3 trials), "Non-Small Cell Lung Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "Advanced Gastric Cancer" (1 trials) and "Advanced/Metastatic Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Queen Elizabeth Hospital; Clinical Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Queen Elizabeth Hospital; Clinical Oncology
Most popular intervention types in "Queen Elizabeth Hospital; Clinical Oncology" are "Drug" (13 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Alectinib" (2 trials), "Capecitabine" (2 trials), "Docetaxel" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Queen Elizabeth Hospital; Clinical Oncology
The vast majority of trials in "Queen Elizabeth Hospital; Clinical Oncology" are
13 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Queen Elizabeth Hospital; Clinical Oncology
Currently, there are NaN active trials in "Queen Elizabeth Hospital; Clinical Oncology".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Queen Elizabeth Hospital; Clinical Oncology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Queen Elizabeth Hospital; Clinical Oncology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".